Scientific Consensus Building

🌍 Why “Consensus-Based” Matters in Antimicrobial Stewardship Antimicrobial resistance (AMR) is not just a tomorrow problem — it’s already eroding our ability to treat infections. The success of stewardship programs depends less on isolated expert opinion and more on agreement across disciplines, settings, and regions. That’s where consensus-based antimicrobial stewardship becomes powerful. 🔑 What “consensus-based” means in this context Defining core competencies, guidelines, and metrics through structured, stakeholder-inclusive methods (e.g. Delphi panels, expert working groups) Harmonizing practices across different healthcare settings — hospitals, clinics, long-term care Ensuring alignment with local microbiology, resistance patterns, and resource constraints 📊 Key advantages Greater buy-in from physicians, pharmacists, microbiologists, infection control — consensus means “we all own this” More adaptable frameworks (versus rigid rules) that can be tailored locally Standardized measurement / benchmarking across institutions facilitates scale and spread of good practices 🧭 Real-world examples & evidence In the UK, a national consensus was established to define stewardship and AMR competencies for undergraduate medical education. Experts have also proposed consensus metrics to assess the impact of stewardship interventions at the patient level. International efforts are underway to create core competencies for antimicrobial stewardship teams using structured consensus procedures. ✨ What does success look like? Clear, co-created stewardship guidelines that clinicians accept and follow Measurable outcomes (antibiotic use, resistance trends, patient outcomes) tracked uniformly A culture shift: stewardship becomes part of everyday decision making, not an add-on Local adaptation without losing fidelity to the consensus framework 🛠 Tips to build or strengthen consensus-based stewardship in your setting Start with stakeholder mapping — include physicians, nurses, pharmacists, microbiologists, infection preventionists Use structured methods (Delphi rounds, consensus workshops) rather than ad hoc meetings Pilot in one unit or department, collect feedback, revise Define measurable metrics early and agree on data collection methods Establish feedback loops — share data, discuss deviations, adapt 💡 Call to action: If your organization is working on antimicrobial stewardship: Have you used consensus methods (e.g. Delphi) to define your protocols? Together, we can move from fragmented efforts to harmonized, effective stewardship.

The Delphi Technique – Building Consensus in Pharma Projects In pharmaceutical project management, decisions often involve multiple experts with different perspectives—R&D, QA, Manufacturing, Regulatory, and Supply Chain. The Delphi Technique is a structured way to reach consensus through anonymous expert input, iterative feedback, and refinement. Process involves: Gather inputs from subject matter experts Summarize responses and share back Run multiple rounds until a consensus is formed Use the collective judgment for decision-making Examples API Projects: 1)Selecting the best synthetic route for scale-up when multiple pathways exist 2)Assessing impurity control strategies where analytical teams and process chemists may disagree 3)Deciding vendor qualification priorities when raw material supply is critical Formulation Projects: 4)Choosing between different excipients to balance stability vs. manufacturability 5)Determining risk-based critical quality attributes (CQAs) for validation batches, 6)Forecasting potential challenges in scale-up (e.g., granulation vs. direct compression debates)